SLC35G1
Solute carrier family 35 member G1
Also known as: C10orf60, FLJ33990, S35G1_HUMAN, TMEM20
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q2M3R5
- Gene
- SLC35G1
- Ensembl
- ENSG00000176273
- Chromosome
- 10
- Canonical length
- 365 aa
- Protein class
- Predicted membrane proteins, Transporters
OverviewNCBI Gene
This gene encodes a transmembrane protein which is a member of the drug/metabolite transporter protein superfamily. The encoded protein may play a role in the regulation of calcium levels inside the cell. [provided by RefSeq, Sep 2016]
Canonical amino-acid sequenceUniProt
365 residues, UniProt reviewed canonical sequence.
>Q2M3R5|SLC35G1
1 MRPQDSTGVA ELQEPGLPLT DDAPPGATEE PAAAEAAGAP DRGRCWLCLS SPCCSRTEPE
61 AKKKAPCPGL GLFYTLLSAF LFSVGSLFVK KVQDVHAVEI SAFRCVFQML VVIPCLIYRK
121 TGFIGPKGQR IFLILRGVLG STAMMLIYYA YQTMSLADAT VITFSSPVFT SIFAWICLKE
181 KYSPWDALFT VFTITGVILI VRPPFLFGSD TSGMEESYSG HLKGTFAAIG SAVFAASTLV
241 ILRKMGKSVD YFLSIWYYVV LGLVESVIIL SVLGEWSLPY CGLDRLFLIF IGLFGLGGQI
301 FITKALQIEK AGPVAIMKTM DVVFAFIFQI IFFNNVPTWW TVGGALCVVA SNVGAAIRKW
361 YQSSKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC35G1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 10
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 64 nTPM
Expression across tissuesHPA
Tissue
- duodenum: 64 nTPM
- small intestine: 32 nTPM
- pancreas: 9 nTPM
- colon: 5.7 nTPM
- rectum: 5.5 nTPM
- liver: 3.4 nTPM
Single-cell type
- pituicytes/fscs: 63 nCPM
- enterocytes: 59 nCPM
- peritubular myoid cells: 58 nCPM
- thyrotrophs: 44 nCPM
- late primary spermatocytes: 41 nCPM
- parietal cells: 41 nCPM
Immune cell
- T-reg: 1.1 nTPM
- memory CD4 T-cell: 0.8 nTPM
- naive CD4 T-cell: 0.8 nTPM
- eosinophil: 0.7 nTPM
- memory CD8 T-cell: 0.5 nTPM
- naive CD8 T-cell: 0.5 nTPM
Brain region
- choroid plexus: 2.5 nTPM
- pons: 1 nTPM
- medulla oblongata: 0.8 nTPM
- cerebellum: 0.7 nTPM
- hypothalamus: 0.7 nTPM
- midbrain: 0.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.74
- gnomAD pLI
- 0.16
- gnomAD missense Z
- 0.01
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SLC35G1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC35G1 as an antibody target. Whether an autoantibody or antibody against SLC35G1 could matter depends on whether native SLC35G1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC35G1 is annotated at the cell surface, where native SLC35G1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC35G1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...